These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1903576)

  • 1. MR imaging in chronic partial epilepsy: role of contrast enhancement.
    Elster AD; Mirza W
    AJNR Am J Neuroradiol; 1991; 12(1):165-70. PubMed ID: 1903576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
    Eldevik OP; Brunberg JA
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.
    Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW
    Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
    Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
    Elster AD
    AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnetic resonance imaging of the brain with gadopentetate dimeglumine-DTPA: comparison of T1-weighted spin-echo and 3D gradient-echo sequences.
    Li D; Haacke EM; Tarr RW; Venkatesan R; Lin W; Wielopolski P
    J Magn Reson Imaging; 1996; 6(3):415-24. PubMed ID: 8724406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
    Sanders WP; Silbergleit R; Spickler EM; Barkley GL; Mehta BA
    Invest Radiol; 1995 Nov; 30(11):634-7. PubMed ID: 8557503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional MR imaging and display of intracranial disease: improvements with the MP-RAGE sequence and gadolinium.
    Brant-Zawadzki MN; Gillan GD; Atkinson DJ; Edalatpour N; Jensen M
    J Magn Reson Imaging; 1993; 3(4):656-62. PubMed ID: 8347960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadopentetate dimeglumine in craniospinal magnetic resonance imaging: common uses and some potential pitfalls.
    Hardjasudarma M
    Can Assoc Radiol J; 1992 Apr; 43(2):100-10. PubMed ID: 1562885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.